Edition:
United States

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

4.62USD
21 May 2018
Change (% chg)

-- (--)
Prev Close
$4.62
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
113,297
52-wk High
$6.73
52-wk Low
$1.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.122
FY 2017 Dec '17 0.00 -0.073
Sep '17 0.00 -0.133
Jun '17 0.00 -0.139
Mar '17 0.00 -0.154
FY 2016 Dec '16 0.00 -0.130
Sep '16 0.00 -0.159
Jun '16 0.00 -0.201
Mar '16 0.00 -0.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 10.00
Year Ending Dec-19 3 5.00 15.00 0.00 12.50
Earnings (per share)
Quarter Ending Jun-18 2 -0.12 -0.11 -0.12 --
Quarter Ending Sep-18 2 -0.12 -0.11 -0.12 --
Year Ending Dec-18 2 -0.46 -0.45 -0.46 -0.56
Year Ending Dec-19 3 -0.78 -0.53 -1.06 -0.75
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 222.84 32.59
P/E High - Last 5 Yrs. -- 281.48 47.07
P/E Low - Last 5 Yrs. -- 95.47 24.59
Beta 2.69 0.75 0.79
Price to Sales (TTM) -- 262.06 9.01
Price to Book (MRQ) -- 23.14 4.24
Price to Tangible Book (MRQ) 64.99 26.27 5.79
Price to Cash Flow (TTM) -- 127.68 21.78
% Owned Institutions 12.38 10.94 2.43

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.66
Dividend Yield - 5 Year Avg -- 0.21 0.80
Dividend 5 Year Growth Rate -- 2.35 4.15
Payout Ratio(TTM) -- 46.91 17.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 26.86 5.10
Sales (TTM) vs TTM 1 Yr. Ago -- 150.04 12.65
Sales - 5 Yr. Growth Rate -- 30.10 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 20.63 -158.81 33.25
EPS (TTM) vs TTM 1 Yr. Ago 27.59 -- --
EPS - 5 Yr. Growth Rate -- 46.66 8.54
Capital Spending - 5 Yr. Growth Rate -- 38.70 8.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.50
Current Ratio (MRQ) 2.05 6.54 3.56
LT Debt to Equity (MRQ) 0.00 22.23 12.86
Total Debt to Equity (MRQ) 0.00 25.74 15.83
Interest Coverage (TTM) -- -177.44 35.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 33.95 54.64
Gross Margin - 5 Yr. Avg. -- 54.86 52.74
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -158.47 15.84
Operating Margin (TTM) -- -930.08 -2.34
Operating Margin - 5 Yr. Avg. -- -171.29 11.09
Pre-Tax Margin (TTM) -- -814.97 -0.23
Pre-Tax Margin - 5 Yr. Avg. -- -176.85 11.29
Net Profit Margin (TTM) -- -806.24 -3.64
Net Profit Margin - 5 Yr. Avg. -- -176.13 7.58
Effective Tax Rate (TTM) -- 14.58 31.25
Effective Tax Rate - 5 Yr. Avg. -- 18.23 24.61

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,442,083 721,262,098
Net Income/Employee (TTM) -2,222,286 -1,504,037 83,813,821
Receivable Turnover (TTM) -- 16.37 5.67
Inventory Turnover (TTM) -- 2.46 3.55
Asset Turnover (TTM) 0.00 0.42 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -164.37 -5.46 9.98
Return on Assets - 5 Yr. Avg. -95.66 -0.52 11.07
Return on Investment (TTM) -253.29 -7.75 12.60
Return on Investment - 5 Yr. Avg. -109.96 2.72 14.34
Return on Equity (TTM) -- -10.55 14.49
Return on Equity - 5 Yr. Avg. -259.75 -2.70 15.71
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 35.72 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Galectin Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.38%
# of Holders: 65
Total Shares Held: 4,673,354
3 Mo. Net Change: 983,633
# New Positions: 22
# Closed Positions: 11
# Increased Positions: 33
# Reduced Positions: 19
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.